Behavioral Economics to Improve Flu Vaccination Using EHR Nudges

NACompletedINTERVENTIONAL
Enrollment

80,039

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

February 20, 2024

Study Completion Date

May 20, 2024

Conditions
Behavior, HealthFluFlu Vaccination
Interventions
BEHAVIORAL

Pre-visit patient text messaging

Patients will be sent text message reminders 3 days and 24 hours prior to their scheduled primary care visit. The messages will inform the patient that a flu shot has been reserved for them at their upcoming appointment and encouraging the patient to ask their provider about receiving the vaccine.

BEHAVIORAL

Default pended order

A default pended order for the flu vaccine will be pended to the patient's upcoming primary care encounter and will be visible to the provider during the visit encounter. Clinical staff will have the option of signing the order or dismissing it if they deem it inappropriate for a given patient.

BEHAVIORAL

Monthly peer comparison feedback

Each month, clinicians will be sent an email containing what percent of their eligible patients received the flu vaccine and how that compares to other peer clinicians in the intervention.

BEHAVIORAL

High risk bidirectional pre-visit text messaging

High risk patients randomized to receive the high risk intensification nudge will receive a bidirectional text messaging component prior to their visit. This intervention will query the patient about common questions or concerns about receiving the flu vaccine. If the patient responds, it will provide additional educational materials based on the patient's specific concern(s).

Trial Locations (2)

19104

University of Pennsylvania Health System, Philadelphia

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

University of Washington

OTHER

lead

University of Pennsylvania

OTHER

NCT06057727 - Behavioral Economics to Improve Flu Vaccination Using EHR Nudges | Biotech Hunter | Biotech Hunter